Illinois 95th Regular Session Status: Passed House 1 D cosponsors

HB 1077 — PHARM PRAC-EMER CONTRACEPTION

Last action — Session Sine Die

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 95th Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Amends the Pharmacy Practice Act of 1987. Allows pharmacists to initiate emergency contraception drug therapy in accordance with protocols developed by the pharmacist and an authorized prescriber. Sets forth provisions concerning the protocol, documentation and recordkeeping, pharmacist training and continuing education, and patient profiles and confidentiality. Requires that the Department of Financial and Professional Regulation develop a standardized fact sheet to be provided to the recipient of the emergency contraceptive drugs. Grants rulemaking authority to the Department and requires the Department to adopt emergency rules concerning the administration of the emergency contraception drug therapy provisions. Amends the Medical Practice Act of 1987 and the Illinois Food, Drug and Cosmetic Act to make related changes. Effective immediately.

Bill Text

What changed in the latest version

12 added · 41 removed

Plain-language change summary

The latest version of HB 1077 includes new provisions that give the Department the authority to adopt rules for managing emergency contraception drug therapy initiated by pharmacists. It emphasizes the importance of developing protocols, ensuring proper training for pharmacists, and maintaining patient confidentiality. These changes are significant as they aim to improve access to emergency contraception while ensuring that there's a clear framework for its administration and the training required. The bill is designed to promote safe and effective practices in pharmacy care, benefiting both pharmacists and patients.

→
Previous
Latest
*LRB09503803RAS23834b* HB1077 95TH GENERAL ASSEMBLY State of Illinois and 2008 HB1077 Introduced 2/8/2007, by Rep.
HB1077 Engrossed LRB095 03803 RAS 23834 b AN ACT concerning regulation.
Sara Feigenholtz - David E.
Miller - Julie Hamos SYNOPSIS AS INTRODUCED:
ILCS 60/54.5 ILCS 85/22b new ILCS 620/3.21 from Ch.
56 1/2, par.
503.21 Amends the Pharmacy Practice Act of 1987.
Allows pharmacists to initiate emergency contraception drug therapy in accordance with protocols developed by the pharmacist and an authorized prescriber.
Sets forth provisions concerning the protocol, documentation and recordkeeping, pharmacist training and continuing education, and patient profiles and confidentiality.
Requires that the Department of Financial and Professional Regulation develop a standardized fact sheet to be provided to the recipient of the emergency contraceptive drugs.
Grants rulemaking authority to the Department and requires the Department to adopt emergency rules concerning the administration of the emergency contraception drug therapy provisions.
Amends the Medical Practice Act of 1987 and the Illinois Food, Drug and Cosmetic Act to make related changes.
Effective immediately.
LRB095 03803 RAS 23834 b FISCAL NOTE ACT MAY APPLY A BILL FOR HB1077 LRB095 03803 RAS 23834 b AN ACT concerning regulation.
A written collaborative agreement shall conform to the requirements of Sections 15-15 and 15-20 of the Nursing and HB1077 - 2 - LRB095 03803 RAS 23834 b Advanced Practice Nursing Act.
A written collaborative agreement shall conform to the requirements of Sections 15-15 and 15-20 of the Nursing and HB1077 Engrossed - 2 - LRB095 03803 RAS 23834 b Advanced Practice Nursing Act.
(b-5) An anesthesiologist or physician licensed to practice medicine in all its branches may collaborate with a certified registered nurse anesthetist in accordance with HB1077 - 3 - LRB095 03803 RAS 23834 b Section 15-25 of the Nursing and Advanced Practice Nursing Act.
(b-5) An anesthesiologist or physician licensed to practice medicine in all its branches may collaborate with a certified registered nurse anesthetist in accordance with HB1077 Engrossed - 3 - LRB095 03803 RAS 23834 b Section 15-25 of the Nursing and Advanced Practice Nursing Act.
(d) Nothing in this Act shall be construed to limit the HB1077 - 4 - LRB095 03803 RAS 23834 b delegation of tasks or duties by a physician licensed to practice medicine in all its branches to a licensed practical nurse, a registered professional nurse, or other personnel.
(d) Nothing in this Act shall be construed to limit the HB1077 Engrossed - 4 - LRB095 03803 RAS 23834 b delegation of tasks or duties by a physician licensed to practice medicine in all its branches to a licensed practical nurse, a registered professional nurse, or other personnel.
HB1077 - 5 - LRB095 03803 RAS 23834 b (2) Emergency contraception is a highly cost-effective method of reducing unintended pregnancies and is most effective the earlier it is used.
HB1077 Engrossed - 5 - LRB095 03803 RAS 23834 b (2) Emergency contraception is a highly cost-effective method of reducing unintended pregnancies and is most effective the earlier it is used.
"Collaborative agreement" means an arrangement between a pharmacist and an authorized prescriber that authorizes the pharmacist to dispense emergency contraception to either the patients of the authorized prescriber or individuals who are not the patients of the authorized HB1077 - 6 - LRB095 03803 RAS 23834 b prescriber.
"Collaborative agreement" means an arrangement between a pharmacist and an authorized prescriber that authorizes the pharmacist to dispense emergency contraception to either the patients of the authorized prescriber or individuals who are not the patients of the authorized HB1077 Engrossed - 6 - LRB095 03803 RAS 23834 b prescriber.
The protocol shall authorize a pharmacist to initiate emergency contraception drug therapy and shall be established and HB1077 - 7 - LRB095 03803 RAS 23834 b approved by an authorized prescriber in accordance with rules adopted by the Department.
The protocol shall authorize a pharmacist to initiate emergency contraception drug therapy and shall be established and HB1077 Engrossed - 7 - LRB095 03803 RAS 23834 b approved by an authorized prescriber in accordance with rules adopted by the Department.
(6) A statement that describes how the licensed physician will review the documentation and records made by the pharmacist and that such review shall occur at least HB1077 - 8 - LRB095 03803 RAS 23834 b once every 3 months.
(6) A statement that describes how the licensed physician will review the documentation and records made by the pharmacist and that such review shall occur at least HB1077 Engrossed - 8 - LRB095 03803 RAS 23834 b once every 3 months.
HB1077 - 9 - LRB095 03803 RAS 23834 b (1) current standards for prescribing emergency contraception drug therapy;
HB1077 Engrossed - 9 - LRB095 03803 RAS 23834 b (1) current standards for prescribing emergency contraception drug therapy;
(m) For each emergency contraception drug therapy initiated pursuant to this Section, the pharmacist shall provide the recipient of the emergency contraceptive drugs with a standardized fact sheet developed by the Department that includes, but is not limited to, the indications for use of the drug, the appropriate method for using the drug, the need for medical follow-up and referral information, information on HB1077 - 10 - LRB095 03803 RAS 23834 b sexual assault and referral information, and other appropriate information.
(m) For each emergency contraception drug therapy initiated pursuant to this Section, the pharmacist shall provide the recipient of the emergency contraceptive drugs with a standardized fact sheet developed by the Department that includes, but is not limited to, the indications for use of the drug, the appropriate method for using the drug, the need for medical follow-up and referral information, information on HB1077 Engrossed - 10 - LRB095 03803 RAS 23834 b sexual assault and referral information, and other appropriate information.
(q) Nothing in this Section may be construed as creating a HB1077 - 11 - LRB095 03803 RAS 23834 b duty for any pharmacist to enter into a collaborative agreement to initiate emergency contraception drug therapy with an authorized prescriber, nor creating a duty for any authorized prescriber to enter into a collaborative agreement with a pharmacist to initiate emergency contraception drug therapy.
(q) Nothing in this Section may be construed as creating a HB1077 Engrossed - 11 - LRB095 03803 RAS 23834 b duty for any pharmacist to enter into a collaborative agreement to initiate emergency contraception drug therapy with an authorized prescriber, nor creating a duty for any authorized prescriber to enter into a collaborative agreement with a pharmacist to initiate emergency contraception drug therapy.
(s) The Department shall adopt rules for the administration of this Section within 60 days after the effective date of this amendatory Act of the 95th General Assembly.
(r) The Department shall adopt rules for the administration of this Section within 60 days after the effective date of this amendatory Act of the 95th General Assembly.
⬇ Download PDF
View plain text versions (2)

Action History

  1. Session Sine Die

  2. Rule 19(a) / Re-referred to Rules Committee

  3. Final Action Deadline Extended-9(b) May 25, 2007

  4. Third Reading/Final Action Deadline Extended-9(b) May 18, 2007

  5. Third Reading/Final Action Deadline Extended-9(b) May 10, 2007

  6. Third Reading/Final Action Deadline Extended-9(b) May 3, 2007

  7. Added Co-Sponsor Rep. Marlow H. Colvin

  8. Added Co-Sponsor Rep. Elizabeth Coulson

  9. Added Co-Sponsor Rep. Greg Harris

  10. Fiscal Note Filed

  11. Placed on Calendar Order of 3rd Reading - Short Debate

  12. Second Reading - Short Debate

  13. Placed on Calendar 2nd Reading - Short Debate

  14. Do Pass / Short Debate Human Services Committee; 006-003-000

  15. Added Co-Sponsor Rep. Deborah L. Graham

  16. Added Co-Sponsor Rep. Rosemary Mulligan

  17. Added Co-Sponsor Rep. William Davis

  18. Assigned to Human Services Committee

  19. Referred to Rules Committee

  20. First Reading

  21. Added Chief Co-Sponsor Rep. Julie Hamos

  22. Chief Co-Sponsor Rep. David E. Miller

  23. Filed with the Clerk by Rep. Sara Feigenholtz

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 1 co-sponsors · 182 not signed on

Sponsors (0)

None.

Co-sponsors (1)

Not signed on (182)

182 members have not signed on to this bill.

Show all 182 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 1077 do?
Amends the Pharmacy Practice Act of 1987. Allows pharmacists to initiate emergency contraception drug therapy in accordance with protocols developed by the pharmacist and an authorized prescriber. Sets forth provisions concerning the protocol, documentation and recordkeeping, pharmacist training and continuing education, and patient profiles and confidentiality. Requires that the Department of Financial and Professional Regulation develop a standardized fact sheet to be provided to the recipient of the emergency contraceptive drugs. Grants rulemaking authority to the Department and requires the Department to adopt emergency rules concerning the administration of the emergency contraception drug therapy provisions. Amends the Medical Practice Act of 1987 and the Illinois Food, Drug and Cosmetic Act to make related changes. Effective immediately.
Who sponsors HB 1077?
HB 1077 is sponsored by Sara Feigenholtz (Democrat).
What is the current status of HB 1077?
This bill died with 95th Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 1077?
Track HB 1077 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 1077

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 1077

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →